Pediatric Drugs and Vaccines

Global Market Trajectory & Analytics

MCP-6503

EXECUTIVE ENGAGEMENTS

OUTREACH

11366
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1364
Interactions with Platform & by Email

PARTICIPANTS

341
Unique # Participated

VALIDATIONS

86
Responses Validated*

COMPETITORS

90
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

120

PAGES

240

EDITION

15

PRICE

USD 5600


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Pediatric Drugs and Vaccines estimated at US$100.1 Billion in the year 2020, is projected to reach a revised size of US$148.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Antibiotics, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$36.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Vaccines segment is readjusted to a revised 6.8% CAGR for the next 7-year period.
The Pediatric Drugs and Vaccines market in the U.S. is estimated at US$27.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$31.4 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
In the global Allergy & Respiratory segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$14.1 Billion in the year 2020 will reach a projected size of US$18.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$20.1 Billion by the year 2027, while Latin America will expand at a 5.3% CAGR through the analysis period.

SELECT PLAYERS

Abbott Laboratories; Allergan Inc.; Amgen Inc.; AstraZeneca Plc; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech Inc.; GlaxoSmithKline Plc; Janssen Biologics B.V; Merck & Co. Inc.; Novartis AG; Novo Nordisk A/S; Pfizer Inc.; Sanofi; Shionogi Inc.; Shire Pharmaceuticals Group Plc

SEGMENTS

» Therapeutic Class (Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones, Other Therapeutic Classes)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Pediatrics: A Highly Underserved and Undervalued Group
Recent Market Activity
Pediatric Drugs Market - An Abode of Opportunities
The United States: Largest Market for Pediatric Drugs and Vaccines
Developing Markets to Witness Faster Growth
Antibiotics: Largest Selling Drug Classes
Pediatric Vaccines Market - On High Growth Trajectory
Supply and Demand Dynamics of the Global Vaccine Market
UNICEF Addresses BCG Vaccine Supply Shortage
Access to Vaccines Index: Aiding Increased Access to Vaccines
Recent Advancements/Achievements in the Pediatric Vaccines Space
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Allergan, Inc. (USA)
Amgen, Inc. (USA)
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals Ltd (Switzerland) (A Janssen Pharmaceutical Company)
Merck & Co., Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
3. MARKET TRENDS & DRIVERS
Pediatric Exclusivity Drives Manufacturers’ Interest
Pediatric Exclusitivity Granted to Branded Drugs
New Product Approvals and Pipeline - A Key Growth Propeller
Recent Pediatric Drug Approvals: 2015-2017
Pediatric Drug Approvals: 2011-2014
Phase III Completed Pediatric Drugs: 2015-2017 (As of July 2017)
Ongoing Phase III Pediatric Drugs Clinical Trials: 2015-2017 (As of July 2017)
Potential for Pediatric Drugs Against Obesity-related Conditions
List of Pediatric Drugs for Congestive Heart Failure Treatment
Recent Findings to Help Save Children’s Lives
Challenges of Pediatric Drug Development: Formulation Problems and Ethical Constraints of Clinical Trials
Financial Enticement for Drug Makers to Conduct Dedicated Pediatric Trials
Modeling & Simulation - A Powerful Tool for Pediatric Clinical Study Sponsors
Pharmacometrics Approaches Gain Traction Among US and EU Researchers
Challenges Associated with Adoption of Pharmacometric Approach
Guidelines for Conducting Ethically Correct Clinical Trials
Pediatric Drug Market - Is Off-label Prescription Justified?
Indian Drug Manufacturers Develop Pneumococcal Conjugate Vaccine
High Vaccination Costs: A Major Hindrance for Pneumonia Vaccination
Vaccine Refusal by Parents - A Growing Trend in the US Market
Orphan Drugs for Pediatric Use Gain Popularity
List of FDA Approved Orphan Drugs: 2015-2016
List of FDA Designated Orphan Drugs: 2015-2017
Pediatric Review Vouchers Foster Innovation in Rare Pediatric Drugs
Need for Higher Focus on Fixed-Dose Combination for Pediatric HIV Infections
Approved Pediatric Antiretroviral Drugs for HIV Treatment
Highly Fragmented Growth Hormone Market
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pediatric Drugs and Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Allergy & Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Allergy & Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Allergy & Respiratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for CNS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for CNS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CNS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Hormones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hormones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hormones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Therapeutic Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Therapeutic Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Therapeutic Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Pediatric Drugs and Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pediatric Drugs and Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pediatric Drugs and Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Breakdown of Value Sales for Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones and Other Therapeutic Classes for the Years 2012, 2020 & 2027
Total Companies Profiled: 90

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com